NUVEEN ASSET MANAGEMENT, LLC Alnylam Pharmaceuticals, Inc. Transaction History

NUVEEN ASSET MANAGEMENT, LLC portfolio value:

$3.32B
portfolio value

NUVEEN ASSET MANAGEMENT, LLC quarter portfolio value change:

+37.24%
quarter

Alnylam Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +5486.11% 16.29M shares 3.27B $200.16 16.59M
Q2 2022 share Decrease -17.95% -64.99K shares -15.48M $145.85 297.04K
Q1 2022 share Decrease -38.69% -228.50K shares -41.33M $163.29 362.03K
Q4 2021 share Decrease -23.01% -176.48K shares -44.67M $171.03 590.54K
Q3 2021 put Decrease -100.00% -31K shares -5K $188.81 0
Q3 2021 share Increase +17.46% 114.02K shares 34.12M $188.81 767.03K
Q2 2021 put Increase 0.00% 31K shares 5K $169.52 31K
Q2 2021 share Increase +9.57% 57.00K shares 26.54M $169.52 653.00K
Q1 2021 share Decrease -0.45% -2.7K shares 6.33M $141.19 596K
Q4 2020 share Increase +40.09% 171.32K shares 15.58M $129.97 598.7K
Q3 2020 share Decrease -5.78% -26.19K shares -4.95M $145.6 427.37K
Q2 2020 share Decrease -11.91% -61.3K shares 11.13M $148.11 453.56K
Q1 2020 share Increase +27.58% 111.31K shares 9.56M $108.85 514.86K
Q4 2019 share Decrease -3.04% -12.65K shares 13.00M $115.17 403.55K
Q3 2019 share Increase +6.54% 25.55K shares 5.12M $80.42 416.21K
Q2 2019 share Increase 0.00% 390.66K shares 28.34M $72.56 390.66K